Differences
This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revisionBoth sides next revision | ||
biocanrx [2022/09/28 09:40] liam [Affiliations] | biocanrx [2023/07/10 20:24] (current) liam [Affiliations] | ||
---|---|---|---|
Line 38: | Line 38: | ||
* [[pharmaceutical_companies: | * [[pharmaceutical_companies: | ||
* [[C17 Council]] | * [[C17 Council]] | ||
+ | * [[Canada' | ||
* [[Canadian Breast Cancer Network]] | * [[Canadian Breast Cancer Network]] | ||
* [[Canadian Cancer Action Network]] | * [[Canadian Cancer Action Network]] | ||
Line 44: | Line 45: | ||
* [[Canadian Cancer Trials Group]] | * [[Canadian Cancer Trials Group]] | ||
* [[Canadian Centre for Applied Research in Cancer Control]] | * [[Canadian Centre for Applied Research in Cancer Control]] | ||
+ | * [[Canadian Institutes of Health Research]] | ||
* [[Canadian Liver Foundation]] | * [[Canadian Liver Foundation]] | ||
* [[Canadian MPN Network]] | * [[Canadian MPN Network]] | ||
* [[Canadian Neuroendocrine Tumour Society]] | * [[Canadian Neuroendocrine Tumour Society]] | ||
* [[Canadian Partnership Against Cancer]] | * [[Canadian Partnership Against Cancer]] | ||
+ | * [[Cancer Care Ontario]] | ||
* [[Cancer Research Society]] | * [[Cancer Research Society]] | ||
* [[Cancer Research UK]] | * [[Cancer Research UK]] | ||
+ | * [[CancerCare Manitoba]] | ||
* [[Cardiff University]] | * [[Cardiff University]] | ||
* [[Carleton University]] | * [[Carleton University]] | ||
Line 62: | Line 66: | ||
* [[Centre de recherche de l' | * [[Centre de recherche de l' | ||
* [[Centre hospitalier de l' | * [[Centre hospitalier de l' | ||
+ | * [[Centre intégré universitaire de santé et de services sociaux de l' | ||
* [[Centre intégré universitaire de santé et de services sociaux de l' | * [[Centre intégré universitaire de santé et de services sociaux de l' | ||
* [[Centre of Excellence on Partnership with Patients and the Public]] | * [[Centre of Excellence on Partnership with Patients and the Public]] | ||
Line 87: | Line 92: | ||
* [[Genome British Columbia]] | * [[Genome British Columbia]] | ||
* [[Genome Québec]] | * [[Genome Québec]] | ||
+ | * [[Health Canada]] | ||
* [[Health Research BC]] | * [[Health Research BC]] | ||
* [[Héma-Québec]] | * [[Héma-Québec]] | ||
Line 92: | Line 98: | ||
* [[Icahn School of Medicine at Mount Sinai]] | * [[Icahn School of Medicine at Mount Sinai]] | ||
* [[ICES]] | * [[ICES]] | ||
- | * [[pharmaceutical_companies: | + | * [[pharmaceutical_companies: |
* [[Institut du cancer de Montréal]] | * [[Institut du cancer de Montréal]] | ||
* [[pharmaceutical_companies: | * [[pharmaceutical_companies: | ||
Line 123: | Line 129: | ||
* [[Myeloma Canada]] | * [[Myeloma Canada]] | ||
* [[National Institutes of Health]] | * [[National Institutes of Health]] | ||
+ | * [[National Research Council Canada]] | ||
+ | * [[Oncopole]] | ||
* [[Ontario Clinical Oncology Group]] | * [[Ontario Clinical Oncology Group]] | ||
* [[Ontario Institute for Cancer Research]] | * [[Ontario Institute for Cancer Research]] | ||
* [[Ontario Parents Advocating for Children with Cancer]] (OPACC) | * [[Ontario Parents Advocating for Children with Cancer]] (OPACC) | ||
+ | * [[Ontario Research Fund]] | ||
+ | * [[Ontario SPOR Support Unit]] | ||
* [[Ontario Veterinary College]] | * [[Ontario Veterinary College]] | ||
* [[Ottawa District 2 Masons]] | * [[Ottawa District 2 Masons]] | ||
Line 200: | Line 210: | ||
</ | </ | ||
+ | |||
+ | Previous partners include [[Canadian Breast Cancer Foundation]], |